Skip to main content

Table 2 Clinical implications of molecular imaging in Alzheimer's disease

From: Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

To increase the understanding of pathophysiological mechanisms

To increase the understanding of time course of disease progression

To understand the differences in time course between pathology and functional changes

To develop diagnostic markers that can predict rate of progression

To enable selection of Alzheimer's disease patients to certain therapy

To measure brain changes after short-term and long-term therapeutic intervention that correlate with clinical symptoms